Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Management and Outcomes of Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Retrospective Study By the Lymphoma Study Association

Julien Lazarovici, MD, Pauline Brice, MD, Lucie Obéric, MD, Isabelle Gaillard, MD, Mathilde Hunault-Berger, MD PhD, Florence Broussais, MD, Serge Bologna, MD, Emmanuel Gyan, MD PhD, Catherine Sebban, MD, Mohamed Touati, MD, Richard Delarue, MD, Frédérique Orsini-Piocelle, MD, Aspasia Stamatoullas, MD, Peggy Dartigues, MD, Marc PE André, MD, Olivier Casasnovas, MD, Nicolas Mounier, MD PhD, Christophe Fermé, MD

Blood (2014) 124 (21): 3054.

https://doi.org/10.1182/blood.V124.21.3054.3054

Published: 2014

Journal Articles

Prognostic Value of Six Germline Single Nucleotide Polymorphisms At the REL , HLA-DRA , GATA3 and PVT1 Loci Identified in a Classical Hodgkin Lymphoma Genome-Wide Association Study: A Meta-Analysis of 601 Patients for Progression-Free Survival From Two Independent Studies

Blood (2012) 120 (21): 3637.

https://doi.org/10.1182/blood.V120.21.3637.3637

Published: 2012

Journal Articles

Lenalidomide Plus Bortezomib and Dexamethasone (RVD) Followed by Lenalidomide Plus Dexamethasone As Salvage Treatment for Myeloma Patients in First Relapse After Autologous Stem Cell Transplantation. Single Institution Experience

Karim Belhadj, MD, Kamel Amraoui, MD, Violaine Safar, MD, Isabelle Gaillard, MD, Taoufik El Gnaoui, MD, Jehan Dupuis, MD, Alain Luciani, MD, PhD, Valérie Molinier-Frenkel, MD, Alain Rahmouni, MD, PhD, Corinne Haioun

Blood (2011) 118 (21): 5143.

https://doi.org/10.1182/blood.V118.21.5143.5143

Published: 2011

Journal Articles

Long-Term Prognostic Significance of Response in Hodgkin Lymphoma Before Autologous Stem Cell Transplantation :Results of the Prospective Multicenter H96 Trial by the GELA/SFGM-TC Study Group

David Sibon, MD, PhD, Matthieu Resche-Rigon, MD, PhD, Franck Morschhauser, Christophe Fermé, Isabelle Gaillard, MD, Ambroise Marcais, MD, Reda Bouabdallah, MD, Catherine Sebban, MD, Gilles Andre Salles, MD, PhD, Pauline Brice, MD

Blood (2011) 118 (21): 3070.

https://doi.org/10.1182/blood.V118.21.3070.3070

Published: 2011

Journal Articles

Cerebrospinal Fluid Immunophenotyping in B-Cell Lymphomas: A Single Centre Experience on 99 Samples.

Anne Plonquet, MD, PhD, Jehan Dupuis, MD, Christo Christov, MD, Christiane Copie-Bergman, MD, PhD, Karim Belhadj, MD, Taoufik El Gnaoui, MD, Isabelle Gaillard, MD, Corinne Haioun, MD

Blood (2007) 110 (11): 2629.

https://doi.org/10.1182/blood.V110.11.2629.2629

Published: 2007

Journal Articles

Response Assessment after an Inductive CHOP or CHOP-Like Regimen with or without Rituximab in 103 Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Integrating 18 Fluorodeoxyglucose Positron Emission Tomography (PET) to the International Workshop Criteria (IWC).

Jehan Dupuis, MD, Emmanuel Itti, MD,PhD, Alain Rahmouni, MD,PhD, Jean-Didier Rain, MD,PhD, Christian Gisselbrecht, MD,PhD, Karim Belhadj, MD, Taoufik El Gnaoui, MD, Isabelle Gaillard, MD, Chieh Lin, MD, Nicolas Mounier, MD,PhD, Philippe Gaulard, MD,PhD, Michel Meignan, MD,PhD, Felix Reyes, MD,PhD, Corinne Haioun, MD

Blood (2006) 108 (11): 2735.

https://doi.org/10.1182/blood.V108.11.2735.2735

Published: 2006

Journal Articles

Benefit of the Adjunction of Rituximab in Salvage Regimen before Autologous Stem-Cell Transplantation (ASCT) in Follicular Lymphoma at Relapse. A Single Institution Study.

Karim Belhadj, MD, Yosr Hicheri, MD, Cécile Pautas, MD, Taoufik El Gnaoui, MD, François Hémery, MD, Christiane Copie-Bergman, MD, Jean-Louis Beaumont, MD, Marie-Hélène Delfau-Larue, MD, Jehan Dupuis, MD, Isabelle Gaillard, MD, Marine Diviné, MD, Félix Reyes, MD, Corinne Haioun, MD

Blood (2005) 106 (11): 2075.

https://doi.org/10.1182/blood.V106.11.2075.2075

Published: 2005

NARROW

Management and Outcomes of Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Retrospective Study By the Lymphoma Study Association

Prognostic Value of Six Germline Single Nucleotide Polymorphisms At the REL , HLA-DRA , GATA3 and PVT1 Loci Identified in a Classical Hodgkin Lymphoma Genome-Wide Association Study: A Meta-Analysis of 601 Patients for Progression-Free Survival From Two Independent Studies

Lenalidomide Plus Bortezomib and Dexamethasone (RVD) Followed by Lenalidomide Plus Dexamethasone As Salvage Treatment for Myeloma Patients in First Relapse After Autologous Stem Cell Transplantation. Single Institution Experience

Long-Term Prognostic Significance of Response in Hodgkin Lymphoma Before Autologous Stem Cell Transplantation :Results of the Prospective Multicenter H96 Trial by the GELA/SFGM-TC Study Group

Cerebrospinal Fluid Immunophenotyping in B-Cell Lymphomas: A Single Centre Experience on 99 Samples.

Response Assessment after an Inductive CHOP or CHOP-Like Regimen with or without Rituximab in 103 Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Integrating 18 Fluorodeoxyglucose Positron Emission Tomography (PET) to the International Workshop Criteria (IWC).

Benefit of the Adjunction of Rituximab in Salvage Regimen before Autologous Stem-Cell Transplantation (ASCT) in Follicular Lymphoma at Relapse. A Single Institution Study.

Email alerts

ASH Publications

American Society of Hematology

Management and Outcomes of Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Retrospective Study By the Lymphoma Study Association

Prognostic Value of Six Germline Single Nucleotide Polymorphisms At the REL , HLA-DRA , GATA3 and PVT1 Loci Identified in a Classical Hodgkin Lymphoma Genome-Wide Association Study: A Meta-Analysis of 601 Patients for Progression-Free Survival From Two Independent Studies

Lenalidomide Plus Bortezomib and Dexamethasone (RVD) Followed by Lenalidomide Plus Dexamethasone As Salvage Treatment for Myeloma Patients in First Relapse After Autologous Stem Cell Transplantation. Single Institution Experience

Long-Term Prognostic Significance of Response in Hodgkin Lymphoma Before Autologous Stem Cell Transplantation :Results of the Prospective Multicenter H96 Trial by the GELA/SFGM-TC Study Group

Cerebrospinal Fluid Immunophenotyping in B-Cell Lymphomas: A Single Centre Experience on 99 Samples.

Response Assessment after an Inductive CHOP or CHOP-Like Regimen with or without Rituximab in 103 Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Integrating 18 Fluorodeoxyglucose Positron Emission Tomography (PET) to the International Workshop Criteria (IWC).

Benefit of the Adjunction of Rituximab in Salvage Regimen before Autologous Stem-Cell Transplantation (ASCT) in Follicular Lymphoma at Relapse. A Single Institution Study.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only